Applisonix develops ultrasound aesthetic treatments.
The board of Maayan Ventures Ltd. (TASE:MAYN) has approved investing up $750,000 in Applisonix Ltd. (TASE:APLS) in several installments. Maayan currently owns 16.7% of Applisonix, which develops ultrasound aesthetic treatments, including the Impresa proprietary ultrasonic depilatory device.
Applisonix's share are up 24.8% so far in 2010, after rising 2.3% yesterday.
Published by Globes [online], Israel business news - www.globes-online.com - on February 15, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010